
Data Integrity in hybrid systems: good practices for paper and electronic systems
Digitalization is advancing steadily in the pharmaceutical industry, but operational reality shows that many organizations are still working

Digitalization is advancing steadily in the pharmaceutical industry, but operational reality shows that many organizations are still working

How AI is transforming environmental monitoring (EMS) from a reactive approach to data-driven predictive models.

In the pharmaceutical and biotechnology industry, quality does not depend solely on procedures or the experience of personnel.

Many technically correct pharmaceutical projects end up generating deviations, delays in qualification or difficulties in inspection for a common reason:

In the pharmaceutical sector, quality is not an attribute added at the end of the project; It is a structural condition that

Requalification (often called periodic qualification) is a fundamental pillar in GMP regulations. In simple terms: It is not enough to

In the pharmaceutical industry, traceability is not an option: it is a critical requirement. However, the new Digital Passport

In the era of Industry 4.0, digital transformation in the regulated sector is no longer an advantage

In the previous article we analyzed what changes Annex 15 brings and what key message the inspectors are sending, as well